CORRECTION
Linkermann A, Heller JO, Prókai A, Weinberg JM, De Zen F, Himmerkus N, Szabó AJ, Bräsen JH, Kunzendorf U, Krautwald S. The RIP1-kinase inhibitor necrostatin-1 prevents osmotic nephrosis and contrast-induced AKI in mice. J Am Soc Nephrol 24: 1545–1557, 2013.
In Figure 3A of this article, the two lower left panels showing ×400 magnifications of the PBS and sham radiocontrast media (RCM) groups were accidentally transposed. This occurred because they both had the same finding of the two conditions (i.e., absence of osmotic nephrosis changes). The correct Figure 3A is printed below.
Figure 3.
Blockade of apoptosis does not protect from RCM-induced osmotic nephrosis or AKI (CIAKI). (A) Eight-week-old male C57Bl/6 mice undergo sham surgery or bilateral renal pedicle clamping 24 hours before intraperitoneal injection of either PBS or the pan-caspase inhibitor zVAD followed by intravenous injection of RCM.